JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Scope & Guideline
Innovating Understanding of Drug Mechanisms
Introduction
Aims and Scopes
- Population Pharmacokinetics and Pharmacodynamics:
The journal emphasizes studies that utilize population pharmacokinetic and pharmacodynamic models to analyze drug behavior in diverse patient populations. This area is crucial for optimizing dosing regimens and understanding variability in drug responses. - Quantitative Systems Pharmacology (QSP):
QSP is a core focus, integrating biological systems modeling with pharmacokinetic and pharmacodynamic principles. This approach aids in predicting drug effects and interactions within complex biological systems, facilitating better drug development strategies. - Mechanistic and Semi-Mechanistic Modeling:
Research that develops mechanistic or semi-mechanistic models to describe drug action and interactions at various biological levels is prevalent. These models help elucidate the underlying biological processes affecting drug behavior. - Innovative Computational Techniques:
The journal showcases the application of advanced computational techniques, including machine learning and artificial intelligence, to pharmacokinetic and pharmacodynamic modeling, aiming to improve predictive accuracy and model efficiency. - Clinical Applications and Translational Research:
There is a strong emphasis on studies that bridge the gap between theoretical modeling and clinical application, particularly in areas such as oncology, rare diseases, and chronic conditions, enhancing the relevance of pharmacometric research to real-world clinical scenarios.
Trending and Emerging
- Integration of Machine Learning in Pharmacometrics:
There is a growing trend in utilizing machine learning techniques to enhance pharmacometric modeling. This includes applications in model selection, optimization, and predictive analytics, which are increasingly recognized for their potential to improve the robustness and efficiency of pharmacokinetic/pharmacodynamic analyses. - Focus on Rare Diseases and Pediatric Populations:
Research addressing pharmacokinetics and pharmacodynamics in rare diseases and pediatric populations is gaining momentum. This reflects a broader recognition of the need for tailored therapeutic strategies in these vulnerable groups. - Virtual Patient Models and Simulations:
The use of virtual patient models and simulations to predict drug responses and optimize treatment regimens is on the rise. These models allow for the exploration of various dosing scenarios and patient characteristics, enhancing translational research efforts. - Mechanistic Insights into Drug Action:
There is an increasing emphasis on studies that provide mechanistic insights into drug action and interactions, particularly through the development of semi-mechanistic and mechanistic models. This trend supports a deeper understanding of how drugs exert their effects at the biological level. - Emphasis on Quantitative Systems Pharmacology (QSP):
QSP is becoming a dominant theme, with a focus on integrating biological data with pharmacometric models to enhance the predictive capabilities of drug development processes. This approach is critical for improving the translation of preclinical findings to clinical outcomes.
Declining or Waning
- Traditional Compartmental Models:
There has been a noticeable decrease in the publication of studies exclusively relying on traditional compartmental models. As more sophisticated modeling approaches, such as physiologically-based pharmacokinetic (PBPK) models, gain traction, the relevance of simpler compartmental methods appears to be waning. - Basic Pharmacokinetic Studies:
Research focused solely on basic pharmacokinetic parameters without integrating pharmacodynamic aspects or clinical implications has decreased. The journal is increasingly favoring studies that combine pharmacokinetics with pharmacodynamics to provide a more comprehensive analysis. - Single-Agent Drug Studies:
The focus on studies examining the pharmacokinetics and pharmacodynamics of single-agent drugs is declining, as there is a growing interest in combination therapies and their complex interactions, particularly in oncology and chronic disease treatment. - Static Modeling Approaches:
Static models that do not account for variability or dynamic changes in drug effects over time are being replaced by more dynamic and flexible modeling approaches. This trend indicates a shift towards methods that better capture the complexities of drug action in real-world scenarios.
Similar Journals
DARU-Journal of Pharmaceutical Sciences
Advancing pharmaceutical knowledge for a healthier tomorrow.DARU-Journal of Pharmaceutical Sciences is a leading peer-reviewed journal published by SPRINGER INT PUBL AG that focuses on the dynamic and rapidly evolving fields of pharmaceutical sciences, including drug discovery, pharmacology, and toxicology. With an impressive Q2 ranking in both Drug Discovery and Miscellaneous Medicine categories for 2023, this journal stands out as a vital resource for researchers, professionals, and students alike, offering a platform for significant contributions to the scientific community. Covering a comprehensive scope from 2000 to 2024 and indexed by Scopus, the journal ranks within the top percentile in its field, with a ranking of #66/313 in Pharmacology and #34/157 in Drug Discovery, reaffirming its impact and relevance. The journal promotes open access to foster widespread dissemination of knowledge in pharmaceutical sciences, ultimately aiming to bridge the gap between research and clinical applications. For those looking to stay at the forefront of pharmaceutical innovation, DARU represents an invaluable connection to the latest studies and breakthrough findings.
CPT-Pharmacometrics & Systems Pharmacology
Fostering collaboration in the realms of pharmacology and modeling.CPT-Pharmacometrics & Systems Pharmacology, published by WILEY, is a leading open access journal dedicated to advancing the fields of pharmacometrics and systems pharmacology. Since its inception in 2012, it has established itself as a vital resource for researchers and practitioners, boasting a remarkable impact factor and occupying prestigious Q1 quartiles in categories such as Cardiology and Cardiovascular Medicine, Modeling and Simulation, and Pharmacology (Medical). The journal covers a broad spectrum of topics aimed at enhancing the understanding of drug development, efficacy, and patient safety through innovative modeling and simulation approaches. With its consistent ranking in the top tiers of its field, CPT-Pharmacometrics & Systems Pharmacology provides invaluable insights and fosters scholarly dialogue among its audience, including researchers, educators, and students. The journal is accessible to all, promoting knowledge dissemination and collaborative growth in the pharmacology community.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Enhancing Understanding of Pharmacological Treatments and ToxicologyBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.
JOURNAL OF PHARMACY AND PHARMACOLOGY
Innovating pharmacology: where science meets therapy.Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.
Drug Research
Exploring New Horizons in Drug DiscoveryDrug Research, published by GEORG THIEME VERLAG KG, is a pivotal journal housed in the vibrant realm of pharmacology and drug discovery. With a commitment to advancing the understanding of medicinal substances, this journal serves as an essential resource for researchers, professionals, and students dedicated to the field. The journal boasts an ISSN of 2194-9379 and an E-ISSN of 2194-9387, reflecting its dual commitment to print and digital accessibility. Despite its status as a Q3 journal in both Drug Discovery and Miscellaneous Medicine categories as of 2023, it continues to offer valuable insights with a focus on the latest innovations, methodologies, and findings in drug research. Based in Germany, Drug Research promotes scholarly communication and collaboration within the scientific community, ensuring that its contributions remain impactful in shaping future therapeutic discoveries. The journal is indexed in relevant databases, enhancing its visibility and reach, thus fostering a robust academic dialogue.
JOURNAL OF CLINICAL PHARMACOLOGY
Empowering Healthcare with Evidence-Based PharmacologyWelcome to the Journal of Clinical Pharmacology, an esteemed publication in the field of pharmacology and medical pharmacology, published by Wiley. Since its inception in 1973, this journal has been at the forefront of disseminating innovative research findings and comprehensive reviews that enhance our understanding of drug therapies and their clinical applications. With an impact factor that reflects its strong reputation and a Scopus ranking placing it in the 64th percentile among 272 journals in medical pharmacology, the journal stands as a critical resource for researchers, healthcare professionals, and students alike. Although currently not an Open Access journal, it provides invaluable insights into therapeutic drug use and safety, the pharmacokinetics of drugs, and the development of new therapeutic strategies. The journal's commitment to advancing the field through high-quality, peer-reviewed articles ensures it remains a vital asset in the continuously evolving landscape of clinical pharmacology.
INDIAN JOURNAL OF PHARMACOLOGY
Bridging research and practice in the world of pharmacology.INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.
ANTI-CANCER DRUGS
Innovating Strategies in Anti-Cancer ResearchANTI-CANCER DRUGS is a leading journal in the domain of cancer research and pharmacology, published by Lippincott Williams & Wilkins. With its inception dating back to 1990 and ongoing publication through 2024, this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements and discoveries in cancer therapeutics. Although classified in the Q3 quartile across relevant categories such as Cancer Research and Oncology, its growing impact is evidenced by its competitive Scopus rankings, positioned within the 30th to 52nd percentiles across various disciplines. The journal remains committed to promoting innovative research that can translate into effective anti-cancer strategies, providing valuable insights into drug development and applications. While it does not currently offer open access, the journal continues to attract a sophisticated readership, making it an essential platform for disseminating significant findings in the ever-evolving field of oncology.
CURRENT OPINION IN PHARMACOLOGY
Advancing Insights in Pharmacological ResearchCurrent Opinion in Pharmacology, an esteemed journal published by Elsevier Science Ltd, encompasses the vital field of pharmacology and drug discovery. With a solid impact factor and recognized as a Q1 journal in both Drug Discovery and Pharmacology categories for 2023, it serves as a premier platform for researchers and professionals to share innovative insights, discuss emerging trends, and explore the complexities of drug development and therapeutic applications. Established in 2001 and running through 2024, this journal provides a critical overview of advances in the field, aiming to inform and inspire the next generation of pharmacological research. Despite lacking Open Access options, it maintains a high standard of scholarly excellence, ensuring that the content remains impactful and relevant to its readers. The journal is based in the Netherlands, representing a key contributor to the academic landscape in pharmacology.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Pioneering insights in clinical pharmacology since 1994.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany, is a vital scholarly platform dedicated to advancing the field of pharmacology through rigorous research and innovative therapeutic strategies. Established in 1994, this journal has maintained its relevance in the evolving landscape of clinical pharmacology, achieving a Q3 rank in both general and medical pharmacology categories as of 2023. With an ISSN of 0946-1965, it is positioned as an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of drug therapy and pharmacological applications. Though it currently does not offer open access, its comprehensive scope covers a wide array of topics within pharmacology, promising to contribute significantly to scientific discussions and knowledge dissemination from 1994 to 2024. Whether you are looking for the latest studies or historical insights, the journal remains a fixture for anyone invested in the pharmacological sciences.